Improving patients’ life through innovation
Founded in 2012, EyeD Pharma is a pharmaceutical company dedicated to improve the life of patients suffering from ophthalmic diseases with unmet medical needs, such as glaucoma or dry eye. To achieve that, we develop innovative therapeutic solutions based on sustained release polymeric micro-implants and inserts.
Driven by unmet medical needs
We are committed to offer innovative therapeutic solutions based on sustained release polymeric micro-implants to address unmet medical needs advised by internationally renowned specialists in ophthalmology.
Guided by strong values
WE ARE PATIENT-DRIVEN
We are on a journey to improve the quality of life of millions of patients suffering from ophthalmic diseases. Our work has no value and no meaning if patients cannot benefit from it.
WE FOSTER DISRUPTIVE INNOVATION
We manage all expertise and processes internally, from idea to market. Passionate about research, development and medical breakthroughs, our innovation experts are keen to go further and think bigger, to offer innovative products that deliver new value.
WE TAKE RESPONSIBILITY
Our aim is to provide the best solutions, while maintaining the highest standards of quality, environment, hygiene and safety. Our responsibility is also to provide quality, sustainable employment and career opportunities in our region.
WE CARE FOR SOLIDARITY
We take care of our teams every day, driven by strong internal values: team spirit, integrity, care and efficiency. We also put our expertise at the service of those who need it most, through international humanitarian missions or by supporting local initiatives. Together, we go further.
With an eye on the future
To support the development of our R&D pipeline based on innovative drug delivery system, we built a unique CDMO gathering tailor-made, patented technologies required to produce micro-implants and inserts.
Today, our team gathers 100+ experts and managers with an average of 18 years’ pharmaceutical expertise in our environment-friendly offices and CDMO in Liège, Belgium.